Peterse H - Search Results

1

The management of lobular carcinoma in situ (LCIS). Is LCIS the same as ductal carcinoma in situ (DCIS)?

Lakhani SR, Audretsch W, Cleton-Jensen AM, Cutuli B, Ellis I, Eusebi V, Greco M, Houslton RS, Kuhl CK, Kurtz J, Palacios J, Peterse H, Rochard F, Rutgers E; EUSOMA. Lakhani SR, et al. Among authors: peterse h. Eur J Cancer. 2006 Sep;42(14):2205-11. doi: 10.1016/j.ejca.2006.03.019. Epub 2006 Jul 28. Eur J Cancer. 2006. PMID: 16876991 Review.

2

Genetic and phenotypic characteristics of pleomorphic lobular carcinoma in situ of the breast.

Chen YY, Hwang ES, Roy R, DeVries S, Anderson J, Wa C, Fitzgibbons PL, Jacobs TW, MacGrogan G, Peterse H, Vincent-Salomon A, Tokuyasu T, Schnitt SJ, Waldman FM. Chen YY, et al. Among authors: peterse h. Am J Surg Pathol. 2009 Nov;33(11):1683-94. doi: 10.1097/PAS.0b013e3181b18a89. Am J Surg Pathol. 2009. PMID: 19701073 Free PMC article.

3

The Multicenter Morphometric Mammary Carcinoma Project (MMMCP). A nationwide prospective study on reproducibility and prognostic power of routine quantitative assessments in The Netherlands.

Baak JP, van Diest PJ, Ariens AT, van Beek MW, Bellot SM, Fijnheer J, van Gorp LH, Kwee WS, Los J, Peterse HC, et al. Baak JP, et al. Among authors: peterse hc. Pathol Res Pract. 1989 Nov;185(5):664-70. doi: 10.1016/S0344-0338(89)80213-4. Pathol Res Pract. 1989. PMID: 2696948 Clinical Trial.

4

BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study.

Rijnsburger AJ, Obdeijn IM, Kaas R, Tilanus-Linthorst MM, Boetes C, Loo CE, Wasser MN, Bergers E, Kok T, Muller SH, Peterse H, Tollenaar RA, Hoogerbrugge N, Meijer S, Bartels CC, Seynaeve C, Hooning MJ, Kriege M, Schmitz PI, Oosterwijk JC, de Koning HJ, Rutgers EJ, Klijn JG. Rijnsburger AJ, et al. Among authors: peterse h. J Clin Oncol. 2010 Dec 20;28(36):5265-73. doi: 10.1200/JCO.2009.27.2294. Epub 2010 Nov 15. J Clin Oncol. 2010. PMID: 21079137 Clinical Trial.

5

Using histopathology breast cancer data to reduce clinical target volume margins at radiotherapy.

Stroom J, Schlief A, Alderliesten T, Peterse H, Bartelink H, Gilhuijs K. Stroom J, et al. Among authors: peterse h. Int J Radiat Oncol Biol Phys. 2009 Jul 1;74(3):898-905. doi: 10.1016/j.ijrobp.2009.01.026. Epub 2009 May 4. Int J Radiat Oncol Biol Phys. 2009. PMID: 19409724

6

Continuing risk of ipsilateral breast relapse after breast-conserving therapy at long-term follow-up.

Kreike B, Hart AA, van de Velde T, Borger J, Peterse H, Rutgers E, Bartelink H, van de Vijver MJ. Kreike B, et al. Among authors: peterse h. Int J Radiat Oncol Biol Phys. 2008 Jul 15;71(4):1014-21. doi: 10.1016/j.ijrobp.2007.11.029. Epub 2008 Jan 30. Int J Radiat Oncol Biol Phys. 2008. PMID: 18234444

7

Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas.

Kreike B, van Kouwenhove M, Horlings H, Weigelt B, Peterse H, Bartelink H, van de Vijver MJ. Kreike B, et al. Among authors: peterse h. Breast Cancer Res. 2007;9(5):R65. doi: 10.1186/bcr1771. Breast Cancer Res. 2007. PMID: 17910759 Free PMC article.

8

Predicting a local recurrence after breast-conserving therapy by gene expression profiling.

Nuyten DS, Kreike B, Hart AA, Chi JT, Sneddon JB, Wessels LF, Peterse HJ, Bartelink H, Brown PO, Chang HY, van de Vijver MJ. Nuyten DS, et al. Among authors: peterse hj. Breast Cancer Res. 2006;8(5):R62. doi: 10.1186/bcr1614. Breast Cancer Res. 2006. PMID: 17069664 Free PMC article.

9

Tumor characteristics and detection method in the MRISC screening program for the early detection of hereditary breast cancer.

Kriege M, Brekelmans CT, Peterse H, Obdeijn IM, Boetes C, Zonderland HM, Muller SH, Kok T, Manoliu RA, Besnard AP, Tilanus-Linthorst MM, Seynaeve C, Bartels CC, Meijer S, Oosterwijk JC, Hoogerbrugge N, Tollenaar RA, de Koning HJ, Rutgers EJ, Klijn JG. Kriege M, et al. Among authors: peterse h. Breast Cancer Res Treat. 2007 May;102(3):357-63. doi: 10.1007/s10549-006-9341-6. Epub 2006 Oct 19. Breast Cancer Res Treat. 2007. PMID: 17051427

10

Gene expression profiles of primary breast carcinomas from patients at high risk for local recurrence after breast-conserving therapy.

Kreike B, Halfwerk H, Kristel P, Glas A, Peterse H, Bartelink H, van de Vijver MJ. Kreike B, et al. Among authors: peterse h. Clin Cancer Res. 2006 Oct 1;12(19):5705-12. doi: 10.1158/1078-0432.CCR-06-0805. Clin Cancer Res. 2006. PMID: 17020974

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

48 results

Search Page